Section 1: Anecdotes BPC-157 first entered mainstream discussions when high-profile figures like Joe Rogan and Andrew Huberman mentioned it
Kwon and Park 2015 reported that intra-articular AOD-9604 injections, especially when combined with hyaluronic acid, improved cartilage scores and reduced lameness in a rabbit collagenase-induced osteoarthritis model
We believe that reliable research is built on a chain of trust, and that chain starts with impeccable raw materials
Clinically, BPC-157 is best suited for acute and subacute soft-tissue injuries, including tendon, ligament, muscle, fascia, and periarticular soft-tissue problems
Products are for laboratory research use only not for human or veterinary use, not for diagnostic procedures, and not evaluated by the U.S